Influence of concomitant quinidine administration on dextromethorphan disposition in rats

Journal of Veterinary Pharmacology and Therapeutics

Volumn 27, Issue 2, 2004, Pages 111-114

  Marier, J F ^a   Pope, L E ^a   Yakatan, G J ^a   Berg, J E ^a   Stiles, M ^b   Vachon, P ^c  

^a MDS Inc   (Canada)

^b AVANIR PHARMACEUTICALS   (United States)

^c Faculty of Veterinary Medicine   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DEXTROMETHORPHAN; DEXTRORPHAN; QUINIDINE SULFATE;

AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG POTENTIATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ANTITUSSIVE AGENTS; AREA UNDER CURVE; DEXTROMETHORPHAN; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; ENZYME INHIBITORS; MALE; METABOLIC CLEARANCE RATE; QUINIDINE; RATS; RATS, SPRAGUE-DAWLEY;

EID: 2442464837     PISSN: 01407783     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2885.2004.00559.x     Document Type: Article

References (21)

1. Barber, R.P., Vaughn, J.E., Slemmon, J.R., Salvaterra, P.M., Roberts, E. & Leeman, S.E. (1979) The origin distribution and synaptic relationships of substance P in rat spinal cord. Journal of Comparative Neurology, 184, 331-352.
2. Bem, J.L. & Peck, R. (1992) Dextromethorphan. An overview of safety issues. Drug Safety, 7, 190-199.
3. Bennett, G.J. (1994) Neuropathic pain. In Textbook of Pain, 3rd edn. Eds Wall, P.D., Melzack, P.D. & Melzack, R. pp. 494-510. Churchill Livingstone, Edinburgh.
4. Bochner, F., Somogyi, A.A. & Chen, Z.R. (1994) Dextromethorphan metabolism in rat: interstrain differences and the fate of individually administered oxidative metabolites. Xenobiotica, 24, 543-552.
5. Boeckmann, A.J., Sheiner, L.B. & Beal, S.L. (1994) NONMEM Users Guide Part V. NONMEM Project Group, University of California, San Francisco, CA.
6. Dematteis, M., Lallement, G. & Mallaret, M. (1998) Dextromethorphan and dextrorphan in rats: common antitussives - different behavioural profiles. Fundamentals of Clinical Pharmacology, 12, 526-537.
7. Fields, H.L. (1990) Pain Syndromes in Neurology. Butterworths, London.
8. Fürst, J. (1999) Transmitters involved in antinociception in the spinal cord. Brain Research Bulletin, 48, 129-141.
9. Gibaldi, M. & Perrier, D. (1982) Multicompartmental models. In Pharmacokinetics, 2nd edn. pp. 45-111. Marcel-Decker, Inc., New York.
10. Hokfelt, T., Eide, R., Johansson, O., Luft, R., Nilsson, G. & Arimura, A. (1976) Immunohistochemical evidence for separate populations of somatostatin-containing and substance P-containing primary afferent neurons. Neuroscience, 1, 131-136.
11. Kerry, N.L., Somogyi, A.A., Mikus, G. & Bochner, F. (1993) Primary and secondary oxidative metabolism of dextromethorphan. In vitro studies with female Sprague-Dawley and Dark Agouti rat liver microsomes. Biochemical Pharmacology, 45, 833-839.
12. Liu, H., Wang, H., Sheng, M., Jan, Y.N. & Basbaum, A.I. (1994) Evidence for presynaptic NMDA autoreceptors in the spinal cord dorsal horn. Proceedings of the National Academy of Sciences of the United States of America, 91, 8383-8387.
13. Liu, H., Mantyh, P.W. & Basbaum, A.I. (1997) NMDA-receptor regulation of substance P release from primary afferents nociceptors. Nature, 386, 721-724.
14. Nlcholson, K.L., Hayes, B.A. & Balster, R.L. (1999) Evaluation of the reinforcing properties and phencyclidine-like discriminative stimulus effects of dextromethorphan and dextrorphan in rats and rhesus monkeys. Psychopharmacology, 146, 49-59.
15. Sang, C.N. (2000) NMDA-receptor antagonists in neuropathic pain: experimental methods to clinical trials. Journal of Pain Symptom Management, 19, S21-S25.
16. Sindrup, S.H. & Jensen, T.S. (1999) Efficacy of pharmacological treatments of neuropathic pain: an update and effect related to mechanisms of drug action. Pain, 83, 389-400.
17. Steinberg, G.K., Kunis, D., Delapaz, R. & Poljak, A. (1993) Neuroprotection following focal cerebral ischaemia with the NMDA antagonist dextromethorphan, has a favourable dose response profile. Neurological Research, 15, 174-180.
18. Szekely, J.I., Sharpe, L.G. & Jaffe, J.H. (1991) Induction of phencyclidine-like behavior in rats by dextrorphan but not dextromethorphan. Pharmacological Biochemical Behavior, 40, 381-386.
19. Tranquilli, W. (2002) Physiology of chronic pain. In Veterinary Anesthesia and Pain Management Secrets. Ed. Green, S.A. pp. 345-347. Hanley and Belfus Inc., Philadelphia, PA.
20. Yamamoto, T. & Yaksh, T.L. (1991) Stereospecific effects of a nonpeptidic NK1 selective antagonist, CP-96.345: antinociception in the absence of motor dysfunction. Life Sciences, 49, 1955-1963.
21. Zysset, T., Zeugin, T. & Kupfer, A. (1988) In-vivo and in-vitro dextromethorphan metabolism in SD and DA rat. An animal model of the debrisoquine-type polymorphic oxidation in man. Biochemical Pharmacology, 37, 3155-3160.